More than 20 years of operations without FDA 483 observations and no critical or major findings. We adhere to the highest quality standards in every aspect of our processes, ensuring top pharma quality operations, sustainability, and continuous improvement and investment for your Small Molecule APIs and Intermediates.
Reliability is our top priority.
.
Agility and flexibility are critical to the success of any API project. Our integrated end-to-end solutions from lab to production capacity adapts to your needs in an agile way.
Agile and flexible from gram to tons. From early phases to commercialization.
.
.
.
.
AGC Pharma Chemicals leads the industry, pioneering innovative routes of synthesis. We tackle complex challenges with cutting-edge solutions, ensuring superior drug development.
Extensive knowledge and experience in the chemicals sector, especially in fluorinated substances.
.
.
The Power of Small Particles: Understanding Micronization in Small Molecule APIs
Jun Kurihara new CEO of AGC Pharma Chemicals
AGC Pharma Chemicals to join BOS Basel 2025
© 2025 AGC Pharma Chemicals Europe S.L.U. All rights reserved.
